The role of cerebral 5-hydroxytryptamine for convulsive threshold and anticonvulsant effect of acetazolamide in rats
- PMID: 138403
The role of cerebral 5-hydroxytryptamine for convulsive threshold and anticonvulsant effect of acetazolamide in rats
Abstract
The effect of various substances modifying the activity of serotoninergic system on convulsive threshold and anticonvulsant effect of acetazolamide (ACA) in rats was studied using the electric test. The obtained results are suggestive of 5-hydroxytryptamine (5-HT) playing a significant role for convulsive threshold. On the other hand, the changes in the potency of anticonvulsant effect of ACA resulting from administration of substances altering the level of cerebral 5-HT seems to be secondary to the effect of these substances on convulsive threshold. Additionally, the ACA doses being effective as anticonvulsant were found to increase the cerebral level of 5-hydroxyindoleacetic acid (5-HIAA) and to accelerate the 5-HT turnover.
Similar articles
-
Convulsive thresholds and the activity of anticonvulsants in electroseizure test. The role of serotoninergic system.Pol J Pharmacol Pharm. 1976;28(2):143-55. Pol J Pharmacol Pharm. 1976. PMID: 934946
-
Role of serotoninergic and adrenergic mechanisms in the action of prominal.Acta Physiol Pol. 1979 Sep-Dec;30(5-6):581-7. Acta Physiol Pol. 1979. PMID: 93847
-
The effect of noradrenergic receptor blocking agents on 5-hydroxytryptamine turnover in the brain of rats.Pol J Pharmacol Pharm. 1976 May-Jun;28(4):341-7. Pol J Pharmacol Pharm. 1976. PMID: 135973
-
Actions of drugs that deplete serotonin.Fed Proc. 1977 Jul;36(8):2149-53. Fed Proc. 1977. PMID: 141378 Review. No abstract available.
-
Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.Adv Neurol. 1986;43:629-43. Adv Neurol. 1986. PMID: 2418652 Review.
Cited by
-
Evidence against serotonin involvement in the tonic component of electrically induced convulsions and in carbamazepine anticonvulsant activity.Psychopharmacology (Berl). 1979;66(1):79-85. doi: 10.1007/BF00431994. Psychopharmacology (Berl). 1979. PMID: 120546